Overall, these findings demonstrated that circREPS2 sponged miR-558 and upregulated RUNX3 to inactivate β-catenin signaling, thereby inhibiting the progression and metastasis of GC (Figure 8F). The gene discussed is RUNX3; the disease is gastric cancer.